Arch Biopartners, Inc. (ARCH.V)
1.07
-0.09
(-7.76%)
CAD |
TSXV |
Aug 25, 15:59
Arch Biopartners Total Assets (Quarterly) : 0.4632M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.4632M |
| December 31, 2025 | 0.025M |
| September 30, 2025 | 0.1045M |
| June 30, 2025 | 0.2665M |
| March 31, 2025 | 0.5496M |
| December 31, 2024 | 0.5335M |
| September 30, 2024 | 0.9356M |
| June 30, 2024 | 1.539M |
| March 31, 2024 | 1.789M |
| December 31, 2023 | 0.6365M |
| September 30, 2023 | 1.171M |
| June 30, 2023 | 1.416M |
| March 31, 2023 | 3.693M |
| December 31, 2022 | 0.7181M |
| September 30, 2022 | 0.6216M |
| June 30, 2022 | 1.848M |
| March 31, 2022 | 2.002M |
| December 31, 2021 | 1.514M |
| September 30, 2021 | 2.668M |
| June 30, 2021 | 2.701M |
| March 31, 2021 | 0.3616M |
| December 31, 2020 | 0.7421M |
| September 30, 2020 | 0.7413M |
| June 30, 2020 | 1.808M |
| March 31, 2020 | 0.6483M |
| Date | Value |
|---|---|
| December 31, 2019 | 0.1185M |
| September 30, 2019 | 0.568M |
| June 30, 2019 | 0.9622M |
| March 31, 2019 | 0.1565M |
| December 31, 2018 | 0.37M |
| September 30, 2018 | 0.6727M |
| June 30, 2018 | 1.387M |
| March 31, 2018 | 1.384M |
| December 31, 2017 | 0.2205M |
| September 30, 2017 | 0.0679M |
| June 30, 2017 | 0.0344M |
| March 31, 2017 | 0.297M |
| December 31, 2016 | 0.0853M |
| September 30, 2016 | 0.227M |
| June 30, 2016 | 0.4476M |
| March 31, 2016 | 0.30M |
| December 31, 2015 | 0.4737M |
| September 30, 2015 | 0.6495M |
| June 30, 2015 | 0.7361M |
| March 31, 2015 | 0.9048M |
| December 31, 2014 | 0.3007M |
| September 30, 2014 | 0.4058M |
| June 30, 2014 | 0.2013M |
| March 31, 2014 | 0.2947M |
| December 31, 2013 | 0.0388M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Innovotech, Inc. | 3.585M |
| Kane Biotech, Inc. | 1.811M |
| Quest PharmaTech, Inc. | 27.75M |
| BriaCell Therapeutics Corp. | 36.85M |
| Vaxil Bio Ltd. | 1.294M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.107M |
| Shareholders Equity (Quarterly) | -3.644M |
| Debt to Equity Ratio | -0.7494 |
| Current Ratio | 0.1128 |
| Net Debt Paydown Yield | 0.33% |